InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by 이권선, 首席执行官. Director active across 2 companies, notably 셀바이오휴먼텍. In total, 39 disclosures have been published. History available since 10 March 2026. The latest transaction was disclosed on 1 April 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
39 条申报中的 25 条
Lee Gwon-seon is the CEO of Cellbio Human Tech, an innovative company in the biotechnology sector. He is responsible for the strategic direction and management of operations. His leadership is essential for the development and growth of the company.